Cargando…

Decentralized Open Platform for Vaccination—A German Example: COVID-19-Vacc

The COVID-19 pandemic has massively impacted the health of many people worldwide and poses significant challenges for our social, economic, and political life. Global vaccination should help the world overcome the pandemic and return to a “normal” life. In Germany, the Federal Ministry of Health pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radonjic-Simic, Mirjana, Mahrt, Christian, Niemand, Sven, Speck, Andreas, Windrich, Melanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the authors. Published by Elsevier Ltd 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035131/ http://dx.doi.org/10.3390/joitmc7030186

Ejemplares similares

VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013)

The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation
por: Hamilton, Kyra, et al.
Publicado: (2022)

The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies
por: Goll, Johannes B., et al.
Publicado: (2023)

Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies
por: Goll, Johannes B., et al.
Publicado: (2023)

Platform Architecture for Decentralized Positioning Systems
por: Kasmi, Zakaria, et al.
Publicado: (2017)

brainlife.io: A decentralized and open source cloud platform to support neuroscience research
por: Hayashi, Soichi, et al.
Publicado: (2023)

Parents’ intention to vaccinate their child for COVID-19: A mixed-methods study (CoVAccS–wave 3)
por: Smith, Louise E., et al.
Publicado: (2022)

Development of Immune-Specific Interaction Potentials and Their Application in the Multi-Agent-System VaccImm
por: Woelke, Anna Lena, et al.
Publicado: (2011)

COVID-19 vaccination acceptability in the UK at the start of the vaccination programme: a nationally representative cross-sectional survey (CoVAccS – wave 2)
por: Sherman, S.M., et al.
Publicado: (2022)

Psychosocial factors affecting COVID-19 vaccine uptake in the UK: A prospective cohort study (CoVAccS – Wave 3)
por: Smith, Louise E., et al.
Publicado: (2023)

DeTi: A Decentralized Ticketing Management Platform
por: Rafati Niya, Sina, et al.
Publicado: (2022)

Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial
por: Brekke, Kristin, et al.
Publicado: (2014)

Secure Decentralized IoT Service Platform Using Consortium Blockchain
por: Zhang, Ruipeng, et al.
Publicado: (2022)

Outgroup emotion processing in the vACC is modulated by childhood trauma and CACNA1C risk variant
por: Krautheim, Johannes T, et al.
Publicado: (2018)

COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey
por: Sherman, Susan M., et al.
Publicado: (2020)

Psychological factors associated with reporting side effects following COVID-19 vaccination: A prospective cohort study (CoVAccS – Wave 3)
por: Smith, Louise E., et al.
Publicado: (2023)

The Dat Project, an open and decentralized research data tool
por: Robinson, Danielle C., et al.
Publicado: (2018)

Towards an open and decentralized case law curation ecosystem
por: Panagou, Eleni, et al.
Publicado: (2020)

On social psychopathology: Example with German justice
por: Michailov, M., et al.
Publicado: (2021)

Blockchain by example: a developer's guide to creating decentralized applications using Bitcoin, Ethereum, and Hyperledger
por: Badr, Bellaj, et al.
Publicado: (2018)

VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients
por: Conrad, Anne, et al.
Publicado: (2019)

VACuum INtubation (VACcIN) box restricts the exhaled air dispersion generated by simulated cough: description and simulation-based tests of an innovative aerosolization protective prototype
por: Issa, Rami, et al.
Publicado: (2021)

COVISHIELD (AZD1222) VaccINe effectiveness among healthcare and frontline Workers of INdian Armed Forces: Interim results of VIN-WIN cohort study
por: Ghosh, Subhadeep, et al.
Publicado: (2021)

Side-effect expectations from COVID-19 vaccination: Findings from a nationally representative cross-sectional survey (CoVAccS – wave 2)
por: Smith, Louise E., et al.
Publicado: (2022)

Blockchain in Healthcare: A Decentralized Platform for Digital Health Passport of COVID-19 Based on Vaccination and Immunity Certificates
por: Razzaq, Abdul, et al.
Publicado: (2022)

From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials
por: Dulko, Dorothy, et al.
Publicado: (2023)

Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals
por: Winckelmann, Anni, et al.
Publicado: (2018)

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

SinoPedia—A Linked Data Services platform for decentralized knowledge base
por: Chen, Tao, et al.
Publicado: (2019)

Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)
por: Buchwald, Ulrike K., et al.
Publicado: (2020)

Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine
por: Ellefsen-Lavoie, K, et al.
Publicado: (2012)

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
por: Rockstroh, Jürgen K., et al.
Publicado: (2019)

A German School of Recovery: The Example of the Mannheim Municipality
Publicado: (1914)

Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc study
por: Stumpf, Julian, et al.
Publicado: (2022)

The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
por: Brekke, Kristin, et al.
Publicado: (2017)

Leveraging WHO’s Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model
por: Owusu Sekyere, Solomon, et al.
Publicado: (2022)

Institutional quality and COVID-19 vaccination: does decentralization matter?
por: Del Bo, Chiara F.
Publicado: (2023)

Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC)
por: Ziemssen, Tjalf, et al.
Publicado: (2023)

PL-TOON: A Low-Cost Experimental Platform for Teaching and Research on Decentralized Cooperative Control †
por: Peters, Andrés A., et al.
Publicado: (2021)

A Decentralized Receiver in Gaussian Interference
por: Chapman, Christian D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ksg5t2cvaspe9h3b171b0lhta0